Renal integrity in sevoflurane sedation in the intensive care unit with the anesthetic-conserving device: A comparison with intravenous propofol sedation

Anesthesia and Analgesia

Volumn 108, Issue 6, 2009, Pages 1848-1854

  Röhm, Kerstin D ^a   Mengistu, Andinet ^a   Boldt, Joachim ^a   Mayer, Jochen ^a   Beck, Grietje ^b   Piper, Swen N ^a  

^a KLINIKUM LUDWIGSHAFEN   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLGLUCOSAMINIDASE; CREATININE; FENTANYL; FLUORIDE; FUROSEMIDE; GLUTATHIONE TRANSFERASE ALPHA; MIDAZOLAM; PANCURONIUM BROMIDE; PIRITRAMIDE; PROPOFOL; SEVOFLURANE; THIOPENTAL; ETHER DERIVATIVE; GLUTATHIONE TRANSFERASE; HYPNOTIC SEDATIVE AGENT; INHALATION ANESTHETIC AGENT;

ABDOMINAL SURGERY; ADULT; AGED; AGITATION; ANESTHESIA INDUCTION; ARTERIAL GAS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DELIRIUM; DEVICE; DIURETIC THERAPY; DRUG EXPOSURE; END TIDAL CARBON DIOXIDE TENSION; ENDOTRACHEAL INTUBATION; FEMALE; FLUID THERAPY; HEMOGLOBIN BLOOD LEVEL; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY PARENCHYMA; MAJOR CLINICAL STUDY; MALE; OUTCOME VARIABLE; POLYURIA; POSTOPERATIVE NAUSEA; POSTOPERATIVE PERIOD; POSTOPERATIVE VOMITING; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SEDATION; SIDE EFFECT; SINGLE BLIND PROCEDURE; STATISTICAL SIGNIFICANCE; THORAX SURGERY; URINE LEVEL; URINE VOLUME; VASCULAR SURGERY; BLEEDING; BLOOD; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; CONSCIOUS SEDATION; INTENSIVE CARE; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY DISEASE; KIDNEY FUNCTION TEST; MIDDLE AGED; POSTOPERATIVE COMPLICATION;

AGED; AGED, 80 AND OVER; ANESTHETICS, INHALATION; BLOOD LOSS, SURGICAL; CONSCIOUS SEDATION; FEMALE; FLUID THERAPY; FLUORIDES; GLUTATHIONE TRANSFERASE; HUMANS; HYPNOTICS AND SEDATIVES; INJECTIONS, INTRAVENOUS; INTENSIVE CARE; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; MALE; METHYL ETHERS; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROPOFOL; SINGLE-BLIND METHOD;

EID: 66349122997     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e3181a1988b     Document Type: Article

References (28)

1. Enlund M, Wiklund L, Lambert H. A new device to reduce the consumption of a halogenated anaesthetic agent. Anaesthesia 2001;56:429-32
2. Sackey PV, Martling CR, Granath F, Radell PJ. Prolonged isoflurane sedation of intensive care unit patients with the Anesthetic Conserving Device. Crit Care Med 2004;32:2241-6
3. Sackey PV, Martling CR, Nise G, Radell PJ. Ambient isoflurane pollution and isoflurane consumption during intensive care unit sedation with the Anesthetic Conserving Device. Crit Care Med 2005;33:585-90
4. Behne M, Wilke HJ, Harder S. Clinical pharmacokinetics of sevoflurane. Clin Pharmacokinet 1999;36:13-26
5. Patel SS, Goa KL. Sevoflurane. A review of its pharmacodynamic and pharmacokinetic properties and its clinical use in general anaesthesia. Drugs 1996;51:658-700
6. Kharasch ED. Biotransformation of sevoflurane. Anesth Analg 1995;81:S27-S38
7. Cousins MJ, Mazze RI. Methoxyflurane nephrotoxicity. A study of dose response in man. JAMA 1973;225:1611-16
8. Frink EJ Jr, Ghantous H, Malan TP, Morgan S, Fernando J, Gandolfi AJ, Brown BR Jr. Plasma inorganic fluoride with sevoflurane anesthesia: correlation with indices of hepatic and renal function. Anesth Analg 1992;74:231-5
9. Conzen PF, Kharasch ED, Czerner SF, Artru AA, Reichle FM, Michalowski P, Rooke GA, Weiss BM, Ebert TJ. Low-flow sevoflurane compared with low-flow isoflurane anesthesia in patients with stable renal insufficiency. Anesthesiology 2002; 97:578-84
10. Belda JF, Soro M, Badenes R, Meiser A, Garcia ML, Aguilar G, Marti FJ. The predictive performance of a pharmacokinetic model for manually adjusted infusion of liquid sevofluorane for use with the Anesthetic-Conserving Device (AnaConDa): a clinical study. Anesth Analg 2008;106:1207-14
11. Röhm KD, Wolf M, Schöllhorn T, Schellhaas A, Boldt J, Piper SN. Short-term sevoflurane sedation using the Anaesthetic Conserving Device after cardiothoracic surgery. Intensive Care Med 2008;34:1683-9
12. Piper SN, Kumle B, Maleck WH, Kiessling AH, Lehmann A, Röhm KD, Suttner SW, Boldt J. Diltiazem may preserve renal tubular integrity after cardiac surgery. Can J Anaesth 2003;50:285-92
13. Martin J, Parsch A, Franck M, Wernecke KD, Fischer M, Spies C. Practice of sedation and analgesia in German intensive care units: results of a national survey. Crit Care 2005;9:R117-R123
14. Shafer A. Complications of sedation with midazolam in the intensive care unit and a comparison with other sedative regimens. Crit Care Med 1998;26:947-56
15. Vasile B, Rasulo F, Candiani A, Latronico N. The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome. Intensive Care Med 2003;29:1417-25
16. Soukup J, Schärff K, Kubosch K, Rudzki M, Zielonka M, Radke J. Sedation with volatile anaesthetics in ICU: technical performance and current experience (German). Intensiv- und Notfallbehandlung 2007;32:29-36
17. Berton J, Sargentini C, Nguyen JL, Belii A, Beydon L. AnaConDa reflection filter: bench and patient evaluation of safety and volatile anesthetic conservation. Anesth Analg 2007;104:130-4
18. Holaday DA, Smith FR. Clinical characteristics and biotransformation of sevoflurane in healthy human volunteers. Anesthesiology 1981;54:100-6
19. Cousins MJ, Mazze RI, Kosek JC, Hitt BA, Love FV. The etiology of methoxyflurane nephrotoxicity. J Pharmacol Exp Ther 1974;190:530-41
20. Mazze RI, Trudell JR, Cousins MJ. Methoxyflurane metabolism and renal dysfunction: clinical correlation in man. Anesthesiol-ogy 1971;35:247-52
21. Conzen PF, Nuscheler M, Melotte A, Verhaegen M, Leupolt T, Van Aken H, Peter K. Renal function and serum fluoride concentrations in patients with stable renal insufficiency after anesthesia with sevoflurane or enflurane. Anesth Analg 1995;81:569-75
22. Bito H, Atsumi K, Katoh T, Ohmura M. Effects of sevoflurane anesthesia on plasma inorganic fluoride concentrations during and after cardiac surgery. J Anesth 1999;13:156-60
23. Frink EJ Jr, Malan TP Jr, Isner RJ, Brown EA, Morgan SE, Brown BR Jr. Renal concentrating function with prolonged sevoflurane or enflurane anesthesia in volunteers. Anesthesiology 1994; 80:1019-25
24. Goldberg ME, Cantillo J, Larijani GE, Torjman M, Vekeman D, Schieren H. Sevoflurane versus isoflurane for maintenance of anesthesia: are serum inorganic fluoride ion concentrations of concern? Anesth Analg 1996;82:1268-72
25. Higuchi H, Sumikura H, Sumita S, Arimura S, Takamatsu F, Kanno M, Satoh T. Renal function in patients with high serum fluoride concentrations after prolonged sevoflurane anesthesia. Anesthesiology 1995;83:449-58
26. Eger EI II, Koblin DD, Bowland T, Ionescu P, Laster MJ, Fang Z, Gong D, Sonner J, Weiskopf RB. Nephrotoxicity of sevoflurane versus desflurane anesthesia in volunteers. Anesth Analg 1997;84:160-8
27. Kharasch ED, Karol MD, Lanni C, Sawchuk R. Clinical sevoflu-rane metabolism and disposition. I. Sevoflurane and metabolite pharmacokinetics. Anesthesiology 1995;82:1369-78
28. McGrath BJ, Hodgins LR, DeBree A, Frink EJ Jr, Nossaman BD, Bikhazi GB. A multicenter study evaluating the effects of sevoflurane on renal function in patients with renal insufficiency. J Cardiovasc Pharmacol Ther 1998;3:229-34